Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sarah Nolasco"'
Autor:
Robert Hawkins, Kate Fife, Michael Hurst, Meng Wang, Niroshini Naicker, Sarah Nolasco, Tim Eisen, Athena Matakidou, Jason Gordon
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic therapies have demonstrated favourable outcomes in randomised controlled trials, however real-world evidence is limited. Thus, this study aimed to
Externí odkaz:
https://doaj.org/article/d065a4dd2bdb4aab9256cfc32e1e1765
Autor:
Meng Wang, Robert E. Hawkins, Jason Gordon, Niroshini Naicker, Tim Eisen, Michael Hurst, Kate Fife, Sarah Nolasco, Athena Matakidou
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Funder: Bristol Myers Squibb Pharmaceuticals Ltd.
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic therapies have demonstrated favourable outcomes in randomised controlled trials, however real-world
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic therapies have demonstrated favourable outcomes in randomised controlled trials, however real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f8dbf28af7314b66371bcceeed7a35
http://europepmc.org/articles/PMC7368711
http://europepmc.org/articles/PMC7368711